S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

FBIOP Fortress Biotech Inc

6.43

-0.1101 (-1.68%)

Jan 31 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Fortress Biotech (NASDAQ:FBIOP)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Fortress Biotech Charts.

Fortress Biotech (NASDAQ:FBIOP)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Fortress Biotech Charts.

Fortress Biotech Inc News

Fortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCT
Monday 27 January 2025 (6 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 16 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 6 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes Disease
Monday 6 January 2025 (4 weeks ago) • GlobeNewswire Inc.

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Friday 3 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 23 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 16 December 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Friday 15 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (3 months ago) • Edgar (US Regulatory)

Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
Thursday 14 November 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 4 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 25 October 2024 (3 months ago) • Edgar (US Regulatory)

More Fortress Biotech Inc News Articles

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions